Earnings next week$DELL (+4,35%)$CRWD (+4,74%)$ANF (+6,41%)$ZM (+6,57%)$KSS (+3,94%)$WDAY (+1,02%)$BBY (+3,42%)$BBWI (+0,61%)$BLBD (+3,39%)$ADSK (+2,33%)$M (+8,74%)$FLNC$HPQ (+2,09%)$DKS (+5%)$AMBA (+5,53%)$URBN (+5,04%)$DDD (+0,98%)$BURL (+5,79%)$A (+1,75%)$WWD (+2,42%)$HDL$IREN (+10,81%)$GIW$SMTC (+0,88%)$JWN (+5,47%)$NTNX (+4,32%)$HSAI (+3,18%)$LESL (+13,28%)$PFLT (+0,76%)$GES (+0,92%)$ENTA (+1,13%)$ADI (+1,91%)$PNNT (+0,9%)$SUPV (+0,74%)$BLRX (-13,55%)$PD$FRO (+0,43%)$NJR (+2,84%)$ARWR (+2,01%)$TWG$MANU (+0,96%)$YY (-5,25%)$NOAH (-0%)$ICCM$SJM (+0,02%)$CLGN$UNM$GOGL (-0,23%)$TITN (+3,97%)
$CLGN CollPlant nabs $10M milestone from $ABBV (+3,77%) AbbVie for dermal filler productThe share price briefly jumped to just under $9 and was then sold again. Nevertheless, the stock may now show up on some analysts' radar.
Rather risky trade in breast implants 😅Of course this company is about more than that. Regenerative medicine, bio-inks, collagen fillers etc..... The stock has been consolidating for over a month and I am speculating on a rebound.
Rather risky trade in breast implants 😅Of course this company is about more than that. Regenerative medicine, bio-inks, collagen fillers etc..... The stock has been consolidating for over a month and I am speculating on a rebound.
